DWP712 not checked

Daewoong Pharmaceutical Co. LTD.

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
None yet
 
Trials
1 active
2 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Glabellar Lines
Main trialPhase 3
“To evaluate the efficacy and safety of DWP712 Inj. in Subjects with Moderate to Severe Glabellar Lines”In the company’s words, NCT07013279 on ClinicalTrials.gov
Given with
Botox (Allergan)Other companies’ drugs in its trials

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials2

TrialPhaseCompletesWhat it tests
Phase 3Not yet recruiting 31 Dec 2025 Evaluate the Efficacy and Safety of DWP712 With Moderate to Severe Glabellar Lines
Phase 1Completed 26 Feb 2024 Evaluate the Safety and Explore the Efficacy of DWP712 With Moderate to Severe Glabellar Lines
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow DWP712

Following is part of Solo: you see every change to DWP712 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in